These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27731358)

  • 21. Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
    Amit T; Youdim MB; Hochberg Z
    J Clin Endocrinol Metab; 2000 Mar; 85(3):927-32. PubMed ID: 10720017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of hybrid ovine/rat GH receptors to oGH and rat GH in transfected FDC-P1 mouse myeloid cells in vitro.
    Beattie J; Phillips K; Shand JH; Brocklehurst S; Flint DJ; Allan GJ
    Mol Cell Biochem; 2002 Sep; 238(1-2):137-43. PubMed ID: 12349901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly.
    Bernabeu I; Alvarez-Escolá C; Quinteiro C; Lucas T; Puig-Domingo M; Luque-Ramírez M; de Miguel-Novoa P; Fernandez-Rodriguez E; Halperin I; Loidi L; Casanueva FF; Marazuela M
    J Clin Endocrinol Metab; 2010 Jan; 95(1):222-9. PubMed ID: 19850678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegvisomant in the treatment of acromegaly.
    Parkinson C; Scarlett JA; Trainer PJ
    Adv Drug Deliv Rev; 2003 Sep; 55(10):1303-14. PubMed ID: 14499709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of binding properties between 20 kDa human growth hormone (hGH) and hGH receptor (hGHR): the binding affinity for hGHR extracellular domain and mode of receptor dimerization.
    Uchida H; Banba S; Wada M; Matsumoto K; Ikeda M; Naito N; Tanaka E; Honjo M
    J Mol Endocrinol; 1999 Dec; 23(3):347-53. PubMed ID: 10601980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Findings and theoretical considerations on the usefulness of the acid-labile subunit in the monitoring of acromegaly.
    Morrison KM; Wu Z; Bidlingmaier M; Strasburger CJ
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S61-3. PubMed ID: 11527090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone receptor: structure and signal transduction.
    Postel-Vinay MC; Finidori J
    Eur J Endocrinol; 1995 Dec; 133(6):654-9. PubMed ID: 8548048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis.
    Franck SE; Broer L; van der Lely AJ; Kamenicky P; Bernabéu I; Malchiodi E; Delhanty PJD; Rivadeneira F; Neggers SJCMM
    Neuroendocrinology; 2017; 105(2):131-140. PubMed ID: 27513761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with pegvisomant in the treatment of acromegaly.
    Drake WM
    Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S111-4. PubMed ID: 11527081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Janus kinase 2 enhances the stability of the mature growth hormone receptor.
    He K; Loesch K; Cowan JW; Li X; Deng L; Wang X; Jiang J; Frank SJ
    Endocrinology; 2005 Nov; 146(11):4755-65. PubMed ID: 16081639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical use of a growth hormone receptor antagonist in the treatment of acromegaly.
    Drake WM; Parkinson C; Besser GM; Trainer PJ
    Trends Endocrinol Metab; 2001 Nov; 12(9):408-13. PubMed ID: 11595543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologically inactive growth hormone caused by an amino acid substitution.
    Takahashi Y; Shirono H; Arisaka O; Takahashi K; Yagi T; Koga J; Kaji H; Okimura Y; Abe H; Tanaka T; Chihara K
    J Clin Invest; 1997 Sep; 100(5):1159-65. PubMed ID: 9276733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist.
    Wilkinson IR; Ferrandis E; Artymiuk PJ; Teillot M; Soulard C; Touvay C; Pradhananga SL; Justice S; Wu Z; Leung KC; Strasburger CJ; Sayers JR; Ross RJ
    Nat Med; 2007 Sep; 13(9):1108-13. PubMed ID: 17721547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designing a long-acting human growth hormone (hGH) by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of hGH.
    Fares F; Guy R; Bar-Ilan A; Felikman Y; Fima E
    Endocrinology; 2010 Sep; 151(9):4410-7. PubMed ID: 20660071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.
    Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone (GH) status regulates GH receptor and GH binding protein mRNA in a tissue- and transcript-specific manner but has no effect on insulin-like growth factor-I receptor mRNA in the rat.
    Butler AA; Funk B; Breier BH; LeRoith D; Roberts CT; Gluckman PD
    Mol Cell Endocrinol; 1996 Feb; 116(2):181-9. PubMed ID: 8647318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of growth hormone receptor down-regulation.
    Deng L; He K; Wang X; Yang N; Thangavel C; Jiang J; Fuchs SY; Frank SJ
    Mol Endocrinol; 2007 Jul; 21(7):1537-51. PubMed ID: 17488973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of human growth hormone receptor gene transcription by triiodothyronine (T3).
    Mullis PE; Eblé A; Marti U; Bürgi U; Postel-Vinay MC
    Mol Cell Endocrinol; 1999 Jan; 147(1-2):17-25. PubMed ID: 10195688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone receptor antagonists.
    van der Lely AJ; Kopchick JJ
    Neuroendocrinology; 2006; 83(3-4):264-8. PubMed ID: 17047392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone receptor antagonists.
    Kohn DT; Kopchick JJ
    Minerva Endocrinol; 2002 Dec; 27(4):287-98. PubMed ID: 12511851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.